chr1-244855607-G-A
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_031844.3(HNRNPU):c.2169C>T(p.Ala723Ala) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0069 in 1,613,750 control chromosomes in the GnomAD database, including 48 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_031844.3 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HNRNPU | NM_031844.3 | c.2169C>T | p.Ala723Ala | splice_region_variant, synonymous_variant | Exon 12 of 14 | ENST00000640218.2 | NP_114032.2 | |
HNRNPU | NM_004501.3 | c.2112C>T | p.Ala704Ala | splice_region_variant, synonymous_variant | Exon 12 of 14 | NP_004492.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00640 AC: 972AN: 151974Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00577 AC: 1448AN: 250808Hom.: 11 AF XY: 0.00580 AC XY: 786AN XY: 135590
GnomAD4 exome AF: 0.00695 AC: 10165AN: 1461658Hom.: 46 Cov.: 31 AF XY: 0.00689 AC XY: 5010AN XY: 727142
GnomAD4 genome AF: 0.00640 AC: 973AN: 152092Hom.: 2 Cov.: 32 AF XY: 0.00588 AC XY: 437AN XY: 74354
ClinVar
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2025 | HNRNPU: BP4, BP7, BS2 - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 28, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jan 26, 2018 | - - |
Developmental and epileptic encephalopathy, 54 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 04, 2025 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 23, 2016 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at